The North America plasmid DNA contract manufacturing market is witnessing significant growth due to rising biotechnology advancements, increasing clinical research activities, and growing adoption of advanced therapeutic approaches. The region’s strong healthcare ecosystem, presence of established contract manufacturers, and increasing demand for scalable and regulatory-compliant...
SPARK Website
عربي